BLFS Q1 2021 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q1 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$17M+38.5% YoY

Gross Profit

$9M55.2% margin

Operating Income

-$981,000-5.8% margin

Net Income

-$1M-6.6% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+14.4%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$572,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$240M

Total Liabilities

$31M

Stockholders' Equity

$209M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$12M	+38.5%
Gross Profit	$9M	$8M	+22.4%
Operating Income	-$981,000	$370,000	-365.1%
Net Income	-$1M	$22M	-105.0%

Revenue Segments

Product

$14M67%

Rental Revenue

$6M29%

Service Revenue

$736,0004%